CU study presented at ASCO 2015 offers early evidence of genetic differences between CRC in young and old patients, possibly pointing toward different treatments and strategies in combating the young form of the disease.
Cancer caregivers are stressed, potentially impacting the quality of the care they give. A CU Cancer Center clinical trial demonstrates how to help.
"Our research suggests that marginalization of smokers may extend beyond the interpersonal level to attitudes toward political systems and institutions," says Karen Albright, PhD.
Dan Theodorescu, MD, PhD, director of the University of Colorado Cancer Center and professor of...
Theodorescu Receives Prestigious Barringer Medal
April 24, 2015 · Comments Off on Theodorescu Receives Prestigious Barringer Medal
CU Cancer Center Director, Dan Theodorescu, MD, PhD, recently received the Barringer Medal from the American Association of Genitourinary Surgeons for his distinguished contributions to urology.
“Humanized” mice will lead to better testing of cancer immunotherapies
April 23, 2015 · Comments Off on “Humanized” mice will lead to better testing of cancer immunotherapies
New model, XactMice, uses human blood stem cells to grow a "humanized" mouse immune system prior to tumor transplantation.
FACC-29 gathers authenticated canine cancer cell lines for research and drug development
April 22, 2015 · Comments Off on FACC-29 gathers authenticated canine cancer cell lines for research and drug development
Canine cancer cells in the FACC-29 help animal cancer researchers authenticate their cell lines.
Oral milk thistle extract stops colorectal cancer stem cells from growing tumors
April 20, 2015 · Comments Off on Oral milk thistle extract stops colorectal cancer stem cells from growing tumors
Results presented at AACR 2015 show that orally administering the chemical silibinin, purified from milk thistle, slows the ability of colorectal cancer stem cells to grow the disease.
Tumor genome sequencing shows the most frequently altered gene in bladder cancer: TERT
April 20, 2015 · Comments Off on Tumor genome sequencing shows the most frequently altered gene in bladder cancer: TERT
Dan Theodorescu, MD, PhD, director of the CU Cancer Center shows the gene TERT is the most common alteration in bladder cancer
Dietary supplements shown to increase cancer risk
April 20, 2015
AACR amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer prevention cancer research colorado Cancer Survivorship clinical trial colon cancer colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Have you attended one of the Culinary Comfort classes? You don't want to miss out on this unique cooking class! ow.ly/NvsrJ
Drs Bunn, Eckhardt, Lieu, Aisner spotted at McCormick Place first day of #ASCO15